Clinical trial NCT02077725: Measuring the Impact of an Interdisciplinary Polypharmacy Clinic Within a Patient-centered Medical Home
Official title: Measure the Impact of an Interdisciplinary Polypharmacy Clinic Within a Patient-entered Medical Home
Study type: OBSERVATIONAL
Overall status: WITHDRAWN
Conditions: Polypharmacy
Keywords: drug related problems
comprehensive medication review
quality of life
Lead sponsor: Ohio State University
Sponsor class: OTHER
First posted: 2014-03-04
Enrollment: 0
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patients within the general internal medicine patient-centered medical homes of The Ohio State University Division of General Internal Medicine

Brief summary: Title: Measuring the impact of an interdisciplinary polypharmacy clinic within a patient-centered medical home

Objectives:

The primary objective of this project will be to track the types of interventions made in an interdisciplinary polypharmacy clinic to improve medication regimens and medication burden. Polypharmacy has been well documented in the literature as a risk for medication errors, adverse drug events, and morbidity. Team visits, including complete medication reviews, by pharmacists and physicians within a National Committee for Quality Assurance (NCQA) tier 3 patient-centered medical home (PCMH) at an academic medical center, can improve medication regimens. Secondary objectives include (1) measuring each patient's quality of life at baseline and one month post-intervention and (2) tracking the cost of medication additions and discontinuations.

Methods:

Patients taking ten or more chronic medications will be identified for referral to the polypharmacy clinic from a report generated from the electronic medical record. The polypharmacy clinic will be staffed by a pharmacist and medical resident with oversight from an attending physician who specializes in geriatrics. Drug-related problems identified during the visit will be resolved and categorized based upon indication, efficacy, cost, safety, and compliance. The numbers and types of interventions made, both during the primary visit and anticipated in the future, will be tracked. The 12-item short form (SF-12) survey will also be administered at baseline and one month post intervention. The increase or decrease in cost for medications added and removed during these visits will be captured using the average wholesale prices.

Preliminary Results Using descriptive statistics, the types of drug-related problems identified and interventions made will be reported. Changes in quality of life and monthly medication costs will also be described.


Eligibility criteria: Inclusion Criteria:

* Patients on 10 or more chronic medications
* Age 18 or older

Exclusion Criteria:

* Non-English speaking patients

Primary outcomes:
measure: Number and types of drug related problems identified
timeFrame: 1 year
Secondary outcomes:
measure: Assess quality of life at baseline and one month post polypharmacy clinic visit
timeFrame: 1 month
measure: Cost of medication additions and discontinuations
timeFrame: 1 month
Other outcomes:
Locations:
city: Columbus
country: United States
facility: The Ohio State University Division of General Internal Medicine Martha Morehouse
state: Ohio
Study officials:
References: